Researchers are excited about the medication , a groundbreaking dual compound showing significant outcomes in initial trials for body reduction . It acts by targeting several pathways : GLP-1 and GIP, https://katrinahhmk318004.bloggerswise.com/49105495/the-new-possibility-for-body-management